Data:
{
"symbol": "TEVA",
"price": 39.05,
"marketCap": 45479192000,
"beta": 0.873,
"lastDividend": 0,
"range": "18.27-40.79",
"change": -1.17,
"changePercentage": -2.909,
"volume": 1609284,
"averageVolume": 5549167,
"companyName": "Teva Pharmaceutical Industries Limited",
"currency": "USD",
"cik": "0000818686",
"isin": "IL0006290147",
"cusip": "",
"exchangeFullName": "New York Stock Exchange",
"exchange": "NYSE",
"industry": "Drug Manufacturers - Specialty & Generic",
"website": "https://www.tevapharm.com",
"description": "Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). The firm prioritizes several key therapeutic domains: central nervous system disorders, pain management, respiratory ailments, and oncology. In the central nervous system sector, prominent products include Copaxone, intended for relapsing forms of multiple sclerosis; AJOVY, prescribed for preventing migraines; and AUSTEDO, which targets tardive dyskinesia and chorea linked to Huntington's disease. For respiratory conditions, Teva offers medications such as ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick, all designed to treat asthma and chronic obstructive pulmonary disease. The oncology portfolio features therapies like Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. Teva Pharmaceutical Industries Limited is also engaged in a collaboration with MedinCell to advance and commercialize multiple long-acting injectable formulations, notably a risperidone suspension for individuals affected by schizophrenia. The company was established in 1901 and its primary headquarters are located in Tel Aviv-Yafo, Israel.",
"ceo": "Richard D. Francis",
"sector": "Healthcare",
"country": "IL",
"fullTimeEmployees": "32008",
"phone": "972 3 914 8213",
"address": "124 Dvora Hanevi\u2019a Street",
"city": "Tel Aviv",
"state": "TA",
"zip": "6944020",
"image": "https://images.financialmodelingprep.com/symbol/TEVA.png",
"ipoDate": "1982-02-16",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": true,
"isFund": false
}
Data:
{
"symbol": "TEVA",
"name": "Teva Pharmaceutical Industries Limited",
"price": 39.585,
"changePercentage": -0.56519,
"change": -0.225,
"volume": 177782,
"dayLow": 39.4,
"dayHigh": 40.2,
"yearHigh": 40.79,
"yearLow": 18.83,
"marketCap": 46102273334,
"priceAvg50": 36.4118,
"priceAvg200": 33.5382,
"exchange": "NYSE",
"open": 40.2,
"previousClose": 39.81,
"timestamp": 1790775427,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-19",
"v": 37.4204,
"c": 37.47
},
{
"t": "2026-08-20",
"v": 36.9742,
"c": 36.81
},
{
"t": "2026-08-21",
"v": 37.4003,
"c": 37.34
},
{
"t": "2026-08-24",
"v": 36.9685,
"c": 36.93
},
{
"t": "2026-08-25",
"v": 37.8071,
"c": 38.1
},
{
"t": "2026-08-26",
"v": 37.6194,
"c": 37.92
},
{
"t": "2026-08-27",
"v": 37.8511,
"c": 37.62
},
{
"t": "2026-08-28",
"v": 36.6358,
"c": 36.44
},
{
"t": "2026-08-31",
"v": 35.9883,
"c": 36.05
},
{
"t": "2026-09-01",
"v": 36.1928,
"c": 36.19
},
{
"t": "2026-09-02",
"v": 36.9986,
"c": 37.49
},
{
"t": "2026-09-03",
"v": 36.6264,
"c": 36.62
},
{
"t": "2026-09-04",
"v": 36.4045,
"c": 36.36
},
{
"t": "2026-09-08",
"v": 36.529,
"c": 36.76
},
{
"t": "2026-09-09",
"v": 36.8046,
"c": 36.85
},
{
"t": "2026-09-10",
"v": 36.302,
"c": 36.35
},
{
"t": "2026-09-11",
"v": 36.8065,
"c": 37.09
},
{
"t": "2026-09-14",
"v": 38.564,
"c": 38.72
},
{
"t": "2026-09-15",
"v": 38.9784,
"c": 39.25
},
{
"t": "2026-09-16",
"v": 38.8,
"c": 38.53
},
{
"t": "2026-09-17",
"v": 39.26,
"c": 39.19
},
{
"t": "2026-09-18",
"v": 39.0143,
"c": 38.98
},
{
"t": "2026-09-21",
"v": 40.023,
"c": 40.06
},
{
"t": "2026-09-22",
"v": 39.6133,
"c": 39.52
},
{
"t": "2026-09-23",
"v": 39.2457,
"c": 39.01
},
{
"t": "2026-09-24",
"v": 39.7841,
"c": 40.22
},
{
"t": "2026-09-25",
"v": 39.3286,
"c": 39.19
},
{
"t": "2026-09-28",
"v": 38.8039,
"c": 38.88
},
{
"t": "2026-09-29",
"v": 39.6369,
"c": 39.81
},
{
"t": "2026-09-30",
"v": 39.9257,
"c": 39.585
}
],
"vwap_summary": {
"days": 30,
"days_above": 15,
"days_below": 15,
"pct_days_above": 50,
"position": "below",
"gap_pct": -0.85,
"streak_days": 1
}
}
Data:
{
"volume": 177782,
"avgVolume": 5549167,
"short_ratio": [
{
"symbol": "TEVA",
"file_date": "2026-09-29",
"date": "20260929",
"short_volume": 1322860,
"short_exempt_volume": 13561,
"total_volume": 3697734,
"short_volume_ratio": 0.3577,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 39.17,
"vah": 40.72,
"val": 37.44,
"profile": [
{
"price": 35.72,
"volume": 266072
},
{
"price": 35.81,
"volume": 75755
},
{
"price": 35.89,
"volume": 547013
},
{
"price": 35.98,
"volume": 318650
},
{
"price": 36.06,
"volume": 256479
},
{
"price": 36.14,
"volume": 1784942
},
{
"price": 36.23,
"volume": 596970
},
{
"price": 36.31,
"volume": 2249335
},
{
"price": 36.4,
"volume": 2246374
},
{
"price": 36.48,
"volume": 1966048
},
{
"price": 36.56,
"volume": 1351381
},
{
"price": 36.65,
"volume": 1996672
},
{
"price": 36.73,
"volume": 1338701
},
{
"price": 36.82,
"volume": 2713527
},
{
"price": 36.9,
"volume": 1168588
},
{
"price": 36.98,
"volume": 1322426
},
{
"price": 37.07,
"volume": 1038964
},
{
"price": 37.15,
"volume": 500107
},
{
"price": 37.23,
"volume": 581355
},
{
"price": 37.32,
"volume": 857273
},
{
"price": 37.4,
"volume": 577550
},
{
"price": 37.49,
"volume": 1348838
},
{
"price": 37.57,
"volume": 17415
},
{
"price": 37.65,
"volume": 185515
},
{
"price": 37.74,
"volume": 0
},
{
"price": 37.82,
"volume": 30861
},
{
"price": 37.91,
"volume": 356209
},
{
"price": 37.99,
"volume": 49566
},
{
"price": 38.07,
"volume": 50084
},
{
"price": 38.16,
"volume": 16921
},
{
"price": 38.24,
"volume": 254312
},
{
"price": 38.33,
"volume": 280893
},
{
"price": 38.41,
"volume": 812739
},
{
"price": 38.49,
"volume": 1309137
},
{
"price": 38.58,
"volume": 1529517
},
{
"price": 38.66,
"volume": 1209111
},
{
"price": 38.75,
"volume": 1579797
},
{
"price": 38.83,
"volume": 2841369
},
{
"price": 38.91,
"volume": 2474829
},
{
"price": 39.0,
"volume": 4707306
},
{
"price": 39.08,
"volume": 4658958
},
{
"price": 39.17,
"volume": 5222412
},
{
"price": 39.25,
"volume": 2164941
},
{
"price": 39.33,
"volume": 981899
},
{
"price": 39.42,
"volume": 1959990
},
{
"price": 39.5,
"volume": 3082949
},
{
"price": 39.59,
"volume": 1720039
},
{
"price": 39.67,
"volume": 2057963
},
{
"price": 39.75,
"volume": 4225947
},
{
"price": 39.84,
"volume": 2225612
},
{
"price": 39.92,
"volume": 2688710
},
{
"price": 40.01,
"volume": 1037216
},
{
"price": 40.09,
"volume": 730563
},
{
"price": 40.17,
"volume": 1251373
},
{
"price": 40.26,
"volume": 998349
},
{
"price": 40.34,
"volume": 367223
},
{
"price": 40.43,
"volume": 503051
},
{
"price": 40.51,
"volume": 585305
},
{
"price": 40.59,
"volume": 238180
},
{
"price": 40.68,
"volume": 121465
}
],
"sessions": 20
}
}
Data:
{
"symbol": "TEVA",
"marketCap": 46707594875.36,
"enterpriseValueTTM": 59838013875.36,
"evToSalesTTM": 3.438650058275155,
"evToOperatingCashFlowTTM": 20.40030717819334,
"evToFreeCashFlowTTM": 25.122753980524433,
"evToEBITDATTM": 19.41593558476632,
"netDebtToEBITDATTM": 4.2604918344385485,
"currentRatioTTM": 0.8794580084366611,
"incomeQualityTTM": 4.042465843300863,
"grahamNumberTTM": 9.599182252700793,
"grahamNetNetTTM": -20.83054871244635,
"taxBurdenTTM": 0.9919733582974765,
"interestBurdenTTM": 0.3474178758105394,
"workingCapitalTTM": -1886000000,
"investedCapitalTTM": 21503211000,
"returnOnAssetsTTM": 0.01798719391825777,
"operatingReturnOnAssetsTTM": 0.06469975133239168,
"returnOnTangibleAssetsTTM": 0.03463320843298598,
"returnOnEquityTTM": 0.09184755533425845,
"returnOnInvestedCapitalTTM": 0.08995497292382973,
"returnOnCapitalEmployedTTM": 0.10727138333815207,
"earningsYieldTTM": 0.015344272248766935,
"freeCashFlowYieldTTM": 0.050994392225845515,
"capexToOperatingCashFlowTTM": 0.1879748851350859,
"capexToDepreciationTTM": 0.5566458622721557,
"capexToRevenueTTM": 0.0316848096490904,
"salesGeneralAndAdministrativeToRevenueTTM": 0.23727702794735672,
"researchAndDevelopementToRevenueTTM": 0.09809362506126984,
"stockBasedCompensationToRevenueTTM": 0.0073556453323472175,
"intangiblesToTotalAssetsTTM": 0.48063737862859723,
"averageReceivablesTTM": 3447654500,
"averagePayablesTTM": 2661899000,
"averageInventoryTTM": 3203020000,
"daysOfSalesOutstandingTTM": 72.77499904525017,
"daysOfPayablesOutstandingTTM": 119.0250693778244,
"daysOfInventoryOutstandingTTM": 140.89661127597066,
"operatingCycleTTM": 213.67161032122084,
"cashConversionCycleTTM": 94.64654094339645,
"freeCashFlowToEquityTTM": 1923373982,
"freeCashFlowToFirmTTM": 3246024449.420763,
"tangibleAssetValueTTM": -11399764000,
"netCurrentAssetValueTTM": -18340000000,
"grossProfitMarginTTM": 0.5245806397802242,
"ebitMarginTTM": 0.1195436922751657,
"ebitdaMarginTTM": 0.17710452546891986,
"operatingProfitMarginTTM": 0.1492476219240447,
"pretaxProfitMarginTTM": 0.04153161563678685,
"continuousOperationsProfitMarginTTM": 0.041255722217902406,
"netProfitMarginTTM": 0.041198256238743444,
"bottomLineProfitMarginTTM": 0.040760166817662195,
"receivablesTurnoverTTM": 5.015458671089087,
"payablesTurnoverTTM": 3.0665808632412634,
"inventoryTurnoverTTM": 2.5905520132424167,
"fixedAssetTurnoverTTM": 4.111475063243557,
"assetTurnoverTTM": 0.436600855483353,
"quickRatioTTM": 0.6749702160296561,
"solvencyRatioTTM": 0.05329109411214953,
"cashRatioTTM": 0.2320406493672504,
"priceToEarningsRatioTTM": 63.65833174603175,
"priceToEarningsGrowthRatioTTM": 0.11574242135642136,
"forwardPriceToEarningsGrowthRatioTTM": -2.609928685268647,
"priceToEarningsDilutedRatioTTM": 66.84124833333334,
"priceToEarningsDilutedGrowthRatioTTM": 0.14071841754385966,
"priceToBookRatioTTM": 6.026316598091062,
"priceToSalesRatioTTM": 2.684097673672708,
"priceToFreeCashFlowRatioTTM": 19.60999938132745,
"priceToOperatingCashFlowRatioTTM": 15.928734177389583,
"debtToAssetsRatioTTM": 0.4205265574428582,
"debtToEquityRatioTTM": 2.161863407713143,
"debtToCapitalRatioTTM": 0.6837308033102979,
"longTermDebtToCapitalRatioTTM": 0.6093222474174855,
"financialLeverageRatioTTM": 5.140848703727589,
"workingCapitalTurnoverRatioTTM": -20.39708570852549,
"operatingCashFlowRatioTTM": 0.18747231285951682,
"operatingCashFlowSalesRatioTTM": 0.16855873925030196,
"freeCashFlowOperatingCashFlowRatioTTM": 0.8120251145239886,
"debtServiceCoverageRatioTTM": 0.5762552458763224,
"interestCoverageRatioTTM": 2.98530150427503,
"shortTermOperatingCashFlowCoverageRatioTTM": 0.65621778987862,
"operatingCashFlowCoverageRatioTTM": 0.17500176493818032,
"capitalExpenditureCoverageRatioTTM": 5.3198596146573625,
"dividendPaidAndCapexCoverageRatioTTM": 5.3198596146573625,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 14.936995963090128,
"netIncomePerShareTTM": 0.6153781871244636,
"interestDebtPerShareTTM": 15.133824272961373,
"cashPerShareTTM": 3.1163158798283264,
"bookValuePerShareTTM": 6.658369098712447,
"tangibleBookValuePerShareTTM": -9.78520600858369,
"shareholdersEquityPerShareTTM": 6.654935622317597,
"operatingCashFlowPerShareTTM": 2.517761207725322,
"capexPerShareTTM": 0.4732758738197425,
"freeCashFlowPerShareTTM": 2.04448533304721,
"netIncomePerEBTTTM": 0.9919733582974765,
"ebtPerEbitTTM": 0.2782732153543001,
"priceToFairValueTTM": 6.026316598091062,
"debtToMarketCapTTM": 0.35458569520001104,
"effectiveTaxRateTTM": 0.0066429734228801935,
"enterpriseValueMultipleTTM": 19.41593558476632,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 17257000000
}
],
"dcf": {
"symbol": "TEVA",
"date": "2026-09-29",
"dcf": 18.090983274007435,
"Stock Price": 40.03
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "TEVA",
"reportedCurrency": "USD",
"cik": "0000818686",
"filingDate": "2026-02-03",
"acceptedDate": "2026-02-03 08:58:40",
"fiscalYear": "2025",
"period": "FY",
"revenue": 17257000000,
"costOfRevenue": 8320000000,
"grossProfit": 8938000000,
"researchAndDevelopmentExpenses": 1013000000,
"generalAndAdministrativeExpenses": 1287000000,
"sellingAndMarketingExpenses": 2686000000,
"sellingGeneralAndAdministrativeExpenses": 3973000000,
"otherExpenses": 1794000000,
"operatingExpenses": 6780000000,
"costAndExpenses": 15100000000,
"netInterestIncome": -916000000,
"interestIncome": 0,
"interestExpense": 916000000,
"depreciationAndAmortization": 1002000000,
"ebitda": 3141000000,
"ebit": 2139000000,
"nonOperatingIncomeExcludingInterest": 18000000,
"operatingIncome": 2157000000,
"totalOtherIncomeExpensesNet": -919000000,
"incomeBeforeTax": 1238000000,
"incomeTaxExpense": -180000000,
"netIncomeFromContinuingOperations": 1418000000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": -1000000,
"netIncome": 1410000000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 1410000000,
"eps": 1.23,
"epsDiluted": 1.2,
"weightedAverageShsOut": 1149000000,
"weightedAverageShsOutDil": 1173000000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "TEVA",
"reportedCurrency": "USD",
"cik": "0000818686",
"filingDate": "2026-02-03",
"acceptedDate": "2026-02-03 08:58:40",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 3555945000,
"shortTermInvestments": 0,
"cashAndShortTermInvestments": 3555945000,
"netReceivables": 3708942000,
"accountsReceivables": 3708942000,
"otherReceivables": 0,
"inventory": 3178951000,
"prepaids": 1121983000,
"otherCurrentAssets": 2379963000,
"totalCurrentAssets": 13945784000,
"propertyPlantEquipmentNet": 4424931000,
"goodwill": 15999752000,
"intangibleAssets": 3780941000,
"goodwillAndIntangibleAssets": 19780693000,
"longTermInvestments": 0,
"taxAssets": 2190966000,
"otherNonCurrentAssets": 404994000,
"totalNonCurrentAssets": 26801584000,
"otherAssets": 0,
"totalAssets": 40747368000,
"totalPayables": 2530961000,
"accountPayables": 2530961000,
"otherPayables": 0,
"accruedExpenses": 738989000,
"shortTermDebt": 1819972000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 8365869000,
"totalCurrentLiabilities": 13455791000,
"longTermDebt": 15273763000,
"capitalLeaseObligationsNonCurrent": 287996000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 295995000,
"otherNonCurrentLiabilities": 3519945000,
"totalNonCurrentLiabilities": 19377700000,
"otherLiabilities": 0,
"capitalLeaseObligations": 287996000,
"totalLiabilities": 32833491000,
"treasuryStock": -4127936000,
"preferredStock": 0,
"commonStock": 58000000,
"retainedEarnings": -13762000000,
"additionalPaidInCapital": 28133000000,
"accumulatedOtherComprehensiveIncomeLoss": -2391000000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 7909877000,
"totalEquity": 7913877000,
"minorityInterest": 4000000,
"totalLiabilitiesAndTotalEquity": 40747368000,
"totalInvestments": 0,
"totalDebt": 17381731000,
"netDebt": 13825786000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "TEVA",
"reportedCurrency": "USD",
"cik": "0000818686",
"filingDate": "2026-02-03",
"acceptedDate": "2026-02-03 08:58:40",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 1418000000,
"depreciationAndAmortization": 1002000000,
"deferredIncomeTax": -671000000,
"stockBasedCompensation": 157000000,
"changeInWorkingCapital": -1366000000,
"accountsReceivables": -173000000,
"inventory": 152000000,
"accountsPayables": -15000000,
"otherWorkingCapital": -1330000000,
"otherNonCashItems": 1109000000,
"netCashProvidedByOperatingActivities": 1649000000,
"investmentsInPropertyPlantAndEquipment": -501000000,
"acquisitionsNet": 34000000,
"purchasesOfInvestments": -57000000,
"salesMaturitiesOfInvestments": 42000000,
"otherInvestingActivities": 1219000000,
"netCashProvidedByInvestingActivities": 737000000,
"netDebtIssuance": -1814000000,
"longTermNetDebtIssuance": -1814000000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": 0,
"netCommonStockIssuance": 0,
"commonStockIssuance": 0,
"commonStockRepurchased": 0,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -337000000,
"netCashProvidedByFinancingActivities": -2151000000,
"effectOfForexChangesOnCash": 21000000,
"netChangeInCash": 256000000,
"cashAtEndOfPeriod": 3556000000,
"cashAtBeginningOfPeriod": 3300000000,
"operatingCashFlow": 1649000000,
"capitalExpenditure": -501000000,
"freeCashFlow": 1148000000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 39.585,
"rsi": 58.39422574630122,
"sma20": 38.42325000000002,
"sma50": 36.57649999999999,
"sma200": 33.58512499999999,
"adx": 37.19025479552427,
"atr": 1.34,
"atr_pct": 3.39,
"atr_expansion_pct": 9.6,
"di_plus": 29.4,
"di_minus": 5.9,
"high_52w": 40.22,
"low_52w": 18.34,
"structure": {
"ema8": 39.35033943948942,
"ema21": 38.540142853643964,
"ema50": 37.04479357963232,
"ema200": 32.64864454874288,
"ema10": 39.23597251254872,
"ema20": 38.60260228260152,
"ema10_slope_pct": 1.28,
"ema20_slope_pct": 1.58,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": true,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": false
},
"dist_21ema_pct": 2.7,
"_no_bars": false,
"macd": {
"macd": 0.876,
"signal": 0.886,
"histogram": -0.01
},
"bollinger": {
"mid": 38.42,
"upper": 40.99,
"lower": 35.86,
"width_pct": 13.35
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": 2.7,
"ret_3d": 1.01,
"ret_5d": 1.47,
"roc10_accel": -3.12,
"checks": {
"roc_over_5": false,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.04,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": false,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 0.86,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": true,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 216694971.35
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 1.4,
"iv_rank": 16.0
}
}
}
}
Data:
{
"prior_day": {
"high": 40.27,
"low": 39.38,
"close": 39.59,
"date": "2026-09-30"
},
"woodie_pivots": {
"PP": 39.71,
"R1": 40.03,
"S1": 39.14,
"R2": 40.6,
"S2": 38.81
},
"swing": {
"high_20d": 40.79,
"low_20d": 35.42,
"high_60d": 40.79,
"low_60d": 29.6
},
"orb": {
"high": 40.27,
"low": 39.38,
"date": "2026-09-30"
},
"vwap": 39.87,
"volume_profile": {
"poc": 39.17,
"vah": 40.72,
"val": 37.44,
"sessions": 20
},
"intraday": {
"h1_trend": "flat",
"h1_last": 39.38,
"h1_ema9": 39.5,
"h1_ema21": 39.33,
"m15_trend": "flat",
"m15_last": 39.38,
"m15_ema9": 39.81,
"m15_ema21": 39.69,
"rvol_intraday": 0.66,
"as_of_et": "2026-09-30 09:35"
},
"premarket": {
"date": "2026-09-30",
"high": 40.37,
"low": 39.87,
"last": 40.2,
"volume": 36285,
"gap_pct": 0.98,
"path": "04:05 39.87 -> 07:20 40.00 -> 08:25 40.26 -> 09:05 40.35 -> 09:25 40.20",
"bars": 17,
"last_bar_et": "09:25"
},
"recent_daily": [
{
"d": "2026-08-26",
"o": 37.7,
"h": 38.055,
"l": 37.07,
"c": 37.92,
"v": 4816066.95264
},
{
"d": "2026-08-27",
"o": 37.72,
"h": 38.37,
"l": 37.535,
"c": 37.62,
"v": 4721594.7002
},
{
"d": "2026-08-28",
"o": 37.37,
"h": 37.42,
"l": 36.37,
"c": 36.44,
"v": 3140917.730602
},
{
"d": "2026-08-31",
"o": 36.17,
"h": 36.3347,
"l": 35.62,
"c": 36.05,
"v": 5778765.509941
},
{
"d": "2026-09-01",
"o": 36.52,
"h": 36.55,
"l": 35.85,
"c": 36.19,
"v": 3515716.42269
},
{
"d": "2026-09-02",
"o": 36.65,
"h": 37.59,
"l": 35.742,
"c": 37.49,
"v": 7690282.625872
},
{
"d": "2026-09-03",
"o": 37.98,
"h": 38.06,
"l": 36.33,
"c": 36.62,
"v": 3904536.011402
},
{
"d": "2026-09-04",
"o": 36.4,
"h": 36.93,
"l": 36.13,
"c": 36.36,
"v": 7402523.69458
},
{
"d": "2026-09-08",
"o": 35.89,
"h": 36.965,
"l": 35.42,
"c": 36.76,
"v": 4623970.039268
},
{
"d": "2026-09-09",
"o": 36.82,
"h": 37.315,
"l": 36.47,
"c": 36.85,
"v": 3999774.185493
},
{
"d": "2026-09-10",
"o": 36.37,
"h": 36.75,
"l": 36.04,
"c": 36.35,
"v": 4014361.937972
},
{
"d": "2026-09-11",
"o": 36.46,
"h": 37.11,
"l": 36.06,
"c": 37.09,
"v": 2855422.871499
},
{
"d": "2026-09-14",
"o": 37.66,
"h": 39.22,
"l": 37,
"c": 38.72,
"v": 4381992.319794
},
{
"d": "2026-09-15",
"o": 38.71,
"h": 39.49,
"l": 38.11,
"c": 39.25,
"v": 7127917.463036
},
{
"d": "2026-09-16",
"o": 39.02,
"h": 39.52,
"l": 38.32,
"c": 38.53,
"v": 4821843.476184
},
{
"d": "2026-09-17",
"o": 38.96,
"h": 39.7,
"l": 38.71,
"c": 39.19,
"v": 5521445.708883
},
{
"d": "2026-09-18",
"o": 38.9,
"h": 39.38,
"l": 38.66,
"c": 38.98,
"v": 5477350.130185
},
{
"d": "2026-09-21",
"o": 39.09,
"h": 40.79,
"l": 38.3621,
"c": 40.06,
"v": 5941719.370456
},
{
"d": "2026-09-22",
"o": 39.45,
"h": 40.14,
"l": 39.0506,
"c": 39.52,
"v": 4542856.637631
},
{
"d": "2026-09-23",
"o": 39.68,
"h": 40.09,
"l": 38.92,
"c": 39.01,
"v": 6138747.825558
},
{
"d": "2026-09-24",
"o": 38.74,
"h": 40.31,
"l": 38.63,
"c": 40.22,
"v": 7731632.013781
},
{
"d": "2026-09-25",
"o": 40.1,
"h": 40.25,
"l": 38.93,
"c": 39.19,
"v": 3874734.767884
},
{
"d": "2026-09-28",
"o": 38.36,
"h": 39.11,
"l": 38.3,
"c": 38.88,
"v": 4306547.589413
},
{
"d": "2026-09-29",
"o": 38.9,
"h": 40.24,
"l": 38.665,
"c": 39.81,
"v": 6822717.350275
},
{
"d": "2026-09-30",
"o": 40.2,
"h": 40.275,
"l": 39.38,
"c": 39.585,
"v": 177680.585861
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 0.49,
"etf_rvol": 1.17,
"rs_5d": 0.24,
"leading": true
}
Data:
{
"estimates": [
{
"symbol": "TEVA",
"date": "2030-12-31",
"revenueLow": 19078595004,
"revenueHigh": 19823102057,
"revenueAvg": 19408137124,
"ebitdaLow": 7342791138,
"ebitdaHigh": 7630861925,
"ebitdaAvg": 7470304584,
"ebitLow": 6611020153,
"ebitHigh": 6899090940,
"ebitAvg": 6738533599,
"netIncomeLow": 4860853354,
"netIncomeHigh": 5108731714,
"netIncomeAvg": 4970575774,
"sgaExpenseLow": 4303257193,
"sgaExpenseHigh": 4471183885,
"sgaExpenseAvg": 4377586802,
"epsAvg": 4.23749,
"epsHigh": 4.35527,
"epsLow": 4.14395,
"numAnalystsRevenue": 4,
"numAnalystsEps": 1
},
{
"symbol": "TEVA",
"date": "2029-12-31",
"revenueLow": 18427513240,
"revenueHigh": 19146613026,
"revenueAvg": 18745809309,
"ebitdaLow": 6763693680,
"ebitdaHigh": 7021038007,
"ebitdaAvg": 6877602420,
"ebitLow": 6008555244,
"ebitHigh": 6265899571,
"ebitAvg": 6122463984,
"netIncomeLow": 4342446003,
"netIncomeHigh": 4563884943,
"netIncomeAvg": 4440461883,
"sgaExpenseLow": 4156402968,
"sgaExpenseHigh": 4318598944,
"sgaExpenseAvg": 4228195983,
"epsAvg": 3.78556,
"epsHigh": 3.89078,
"epsLow": 3.702,
"numAnalystsRevenue": 4,
"numAnalystsEps": 1
},
{
"symbol": "TEVA",
"date": "2028-12-31",
"revenueLow": 17386075887,
"revenueHigh": 18250931345,
"revenueAvg": 17895665993,
"ebitdaLow": 5744910972,
"ebitdaHigh": 7016882817,
"ebitdaAvg": 6559014836,
"ebitLow": 4955117508,
"ebitHigh": 6227089353,
"ebitAvg": 5769221372,
"netIncomeLow": 3435986792,
"netIncomeHigh": 4530489633,
"netIncomeAvg": 4136504650,
"sgaExpenseLow": 3921502402,
"sgaExpenseHigh": 4116574181,
"sgaExpenseAvg": 4036442589,
"epsAvg": 3.39577,
"epsHigh": 3.86231,
"epsLow": 2.92923,
"numAnalystsRevenue": 9,
"numAnalystsEps": 2
},
{
"symbol": "TEVA",
"date": "2027-12-31",
"revenueLow": 17065969653,
"revenueHigh": 17273248636,
"revenueAvg": 17125192220,
"ebitdaLow": 5807842908,
"ebitdaHigh": 6034079081,
"ebitdaAvg": 5920960995,
"ebitLow": 4967740712,
"ebitHigh": 5193976885,
"ebitAvg": 5080858799,
"netIncomeLow": 3446848772,
"netIncomeHigh": 3641519853,
"netIncomeAvg": 3544184312.5,
"sgaExpenseLow": 3849301097,
"sgaExpenseHigh": 3896053741,
"sgaExpenseAvg": 3862658995,
"epsAvg": 3.03611,
"epsHigh": 3.10445,
"epsLow": 2.93849,
"numAnalystsRevenue": 9,
"numAnalystsEps": 5
}
],
"price_target": {
"symbol": "TEVA",
"targetHigh": 50,
"targetLow": 42,
"targetConsensus": 45.8,
"targetMedian": 45
},
"ratings": {
"symbol": "TEVA",
"rating": "B-",
"overallScore": 2,
"discountedCashFlowScore": 3,
"returnOnEquityScore": 4,
"returnOnAssetsScore": 3,
"debtToEquityScore": 1,
"priceToEarningsScore": 1,
"priceToBookScore": 2
},
"grades": [
{
"symbol": "TEVA",
"date": "2026-09-04",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-08-12",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-07-28",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-05-06",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-04-30",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-04-30",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-04-30",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-04-30",
"gradingCompany": "UBS",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-04-09",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-03-04",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-02-18",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-02-09",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-01-30",
"gradingCompany": "Barclays",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-01-29",
"gradingCompany": "Truist Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-01-29",
"gradingCompany": "Scotiabank",
"previousGrade": "Sector Outperform",
"newGrade": "Sector Outperform",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2026-01-06",
"gradingCompany": "Jefferies",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2025-12-22",
"gradingCompany": "Piper Sandler",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2025-12-19",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2025-12-16",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2025-12-09",
"gradingCompany": "B of A Securities",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2025-12-08",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2025-11-06",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "TEVA",
"date": "2025-10-03",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Teva Pharmaceutical: 3 Numbers That Explain This Generic-Drug Turnaround",
"url": "https://www.fool.com/investing/2026/09/29/teva-pharmaceutical-numbers-explain-turnaround/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-09-29T09:35:00Z",
"summary": "Teva Pharmaceutical has surged 110% in the last year, hitting a 52-week high of $40.79 per share, driven by its pivot from generic to branded drugs. The company's innovative portfolio of three branded products is projected to generate $3.7 billion in 2026 revenue, while net debt ",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F888659%2Fbiotech-pharma-researchers-talk-lab-1200x800-5b2df79.jpg&w=1200&op=resize"
},
{
"title": "Teva's Branded Drugs Take Center Stage in Its Growth Strategy",
"url": "https://www.zacks.com/stock/news/2997254/teva-s-branded-drugs-take-center-stage-in-its-growth-strategy?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2997254",
"source": "Zacks Investment Research",
"date": "2026-09-29 09:51:07",
"summary": "Teva's branded drugs are driving stronger growth as Austedo, Ajovy and Uzedy gain momentum and its pipeline of new candidates expands.",
"image": "https://images.financialmodelingprep.com/news/tevas-branded-drugs-take-center-stage-in-its-growth-20260929.jpg"
},
{
"title": "Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA\u2122 (denosumab-adet), a Biosimilar to Xgeva\u00ae (denosumab)",
"url": "https://www.globenewswire.com/news-release/2026/09/28/3370248/0/en/teva-continues-biosimilar-momentum-with-u-s-fda-approval-of-degevma-denosumab-adet-a-biosimilar-to-xgeva-denosumab.html",
"source": "GlobeNewsWire",
"date": "2026-09-28 16:00:00",
"summary": "TEL AVIV, Israel, and PARSIPPANY, N.J., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved DEGEVMA\u2122 (denosumab-adet) as a biosimilar to Xgeva\u00ae (denosumab). DEGE",
"image": "https://images.financialmodelingprep.com/news/teva-continues-biosimilar-momentum-with-us-fda-approval-of-20260928.jpg"
},
{
"title": "QRG Capital Management Inc. Purchases 12,925 Shares of Teva Pharmaceutical Industries Ltd. $TEVA",
"url": "https://www.defenseworld.net/2026/09/26/qrg-capital-management-inc-purchases-12925-shares-of-teva-pharmaceutical-industries-ltd-teva.html",
"source": "Defense World",
"date": "2026-09-26 04:03:15",
"summary": "QRG Capital Management Inc. grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) by 17.0% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 89,078 shares of the company's stock after p",
"image": "https://images.financialmodelingprep.com/news/qrg-capital-management-inc-purchases-12925-shares-of-teva-20260926.png"
},
{
"title": "Teva Eyes New Growth Phase After Securing Investment-Grade Ratings",
"url": "https://www.defenseworld.net/2026/09/24/teva-eyes-new-growth-phase-after-securing-investment-grade-ratings.html",
"source": "Defense World",
"date": "2026-09-24 05:03:10",
"summary": "Teva Pharmaceutical Industries (NYSE: TEVA) is planning for greater financial flexibility after receiving investment-grade ratings from all three major credit rating agencies, President and CEO Richard Francis said at the BofA Global Healthcare Conference. Francis said the compan",
"image": "https://images.financialmodelingprep.com/news/teva-eyes-new-growth-phase-after-securing-investmentgrade-ratings-20260924.png"
},
{
"title": "Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET",
"url": "https://www.globenewswire.com/news-release/2026/09/23/3367868/0/en/teva-to-host-conference-call-to-discuss-third-quarter-2026-financial-results-on-november-3-2026-at-8-a-m-et.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-23T20:45:00Z",
"summary": "Teva Pharmaceutical Industries announced it will release its Q3 2026 financial results on November 3, 2026, at 7:00 a.m. ET, followed by a conference call and live webcast at 8:00 a.m. ET. The company is executing its Pivot to Growth strategy focused on expanding its innovative a",
"image": "https://ml-eu.globenewswire.com/Resource/Download/c2001734-949b-4cc2-8021-b4b64eda1f13"
},
{
"title": "Teva Releases Q3 2026 Aide Memoire",
"url": "https://www.globenewswire.com/news-release/2026/09/23/3367867/0/en/teva-releases-q3-2026-aide-memoire.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-23T20:45:00Z",
"summary": "Teva Pharmaceutical Industries Ltd. announced the availability of its Q3 2026 Aide Memoire document to assist investors ahead of third quarter 2026 results, scheduled for release on November 3, 2026, followed by a conference call at 8:00 a.m. ET. The company is transforming into ",
"image": "https://ml-eu.globenewswire.com/Resource/Download/c2001734-949b-4cc2-8021-b4b64eda1f13"
},
{
"title": "Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript",
"url": "https://seekingalpha.com/article/4948974-teva-pharmaceutical-industries-limited-teva-presents-at-bank-of-america-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-23 09:41:42",
"summary": "Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 Transcript",
"image": "https://images.financialmodelingprep.com/news/teva-pharmaceutical-industries-limited-teva-presents-at-bank-of-20260923.jpg"
},
{
"title": "Teva Pharmaceutical Industries (NYSE:TEVA) Insider Brian Savage Sells 7,342 Shares of Stock",
"url": "https://www.defenseworld.net/2026/09/23/teva-pharmaceutical-industries-nyseteva-insider-brian-savage-sells-7342-shares-of-stock.html",
"source": "Defense World",
"date": "2026-09-23 06:11:14",
"summary": "Teva Pharmaceutical Industries Ltd. (NYSE: TEVA - Get Free Report) insider Brian Savage sold 7,342 shares of the stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $38.85, for a total value of $285,236.70. Following the compl",
"image": "https://images.financialmodelingprep.com/news/teva-pharmaceutical-industries-nyseteva-insider-brian-savage-sells-7342-20260923.png"
},
{
"title": "Teva Pharmaceutical Industries (NYSE:TEVA) Director Roberto Mignone Sells 367,600 Shares of Stock",
"url": "https://www.defenseworld.net/2026/09/23/teva-pharmaceutical-industries-nyseteva-director-roberto-mignone-sells-367600-shares-of-stock.html",
"source": "Defense World",
"date": "2026-09-23 04:53:53",
"summary": "Teva Pharmaceutical Industries Ltd. (NYSE: TEVA - Get Free Report) Director Roberto Mignone sold 367,600 shares of Teva Pharmaceutical Industries stock in a transaction that occurred on Friday, September 18th. The shares were sold at an average price of $39.06, for a total transa",
"image": "https://images.financialmodelingprep.com/news/teva-pharmaceutical-industries-nyseteva-director-roberto-mignone-sells-367600-20260923.png"
},
{
"title": "Teva Pharmaceutical Industries Limited (TEVA) Presents at U.S. All Stars Conference Transcript",
"url": "https://seekingalpha.com/article/4948545-teva-pharmaceutical-industries-limited-teva-presents-at-u-s-all-stars-conference-transcript",
"source": "Seeking Alpha",
"date": "2026-09-22 07:19:49",
"summary": "Teva Pharmaceutical Industries Limited (TEVA) Presents at U.S. All Stars Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/teva-pharmaceutical-industries-limited-teva-presents-at-us-all-20260922.jpg"
},
{
"title": "Teva CEO Details Biopharma Pivot, $700M Savings Plan and Growth Pipeline",
"url": "https://www.defenseworld.net/2026/09/22/teva-ceo-details-biopharma-pivot-700m-savings-plan-and-growth-pipeline.html",
"source": "Defense World",
"date": "2026-09-22 05:03:51",
"summary": "Teva Pharmaceutical Industries (NYSE: TEVA) Chief Executive Officer Richard Francis said the company has shifted from being viewed primarily as a generics manufacturer toward a biopharmaceutical company with a growing innovative medicines portfolio, while maintaining and expandin",
"image": "https://images.financialmodelingprep.com/news/teva-ceo-details-biopharma-pivot-700m-savings-plan-and-20260922.png"
},
{
"title": "Medincell's Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY\u00ae at Psych Congress 2026",
"url": "https://www.businesswire.com/news/home/20260920569762/en/Medincells-Partner-Teva-Presented-New-Data-on-Investigational-Olanzapine-LAI-and-UZEDY%C2%AE-at-Psych-Congress-2026/",
"source": "Business Wire",
"date": "2026-09-21 02:00:00",
"summary": "MONTPELLIER, France--(BUSINESS WIRE)--Medincell's partner Teva presented new data on investigational Olanzapine long-acting injectable (LAI) and UZEDY\u00ae, two treatments utilizing Medincell's proprietary BEPO\u00ae technology, licensed to Teva as SteadyTeq\u2122. The findings were presented ",
"image": "https://images.financialmodelingprep.com/news/medincells-partner-teva-presented-new-data-on-investigational-olanzapine-20260921.jpg"
},
{
"title": "New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients",
"url": "https://www.globenewswire.com/news-release/2026/09/18/3364953/0/en/new-teva-study-identifies-the-attributes-that-healthcare-providers-prioritize-when-selecting-a-treatment-for-tardive-dyskinesia-in-older-patients.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-18T20:32:00Z",
"summary": "Teva released findings from a discrete choice experiment showing that healthcare providers prioritize somnolence risk, long-term efficacy data, and drug-drug interaction profiles when selecting treatments for tardive dyskinesia in patients aged 55+. AUSTEDO (deutetrabenazine) was",
"image": "https://ml-eu.globenewswire.com/Resource/Download/c2001734-949b-4cc2-8021-b4b64eda1f13"
},
{
"title": "Teva Highlights New Real-World Data Showing UZEDY\u00ae (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs",
"url": "https://www.globenewswire.com/news-release/2026/09/18/3364952/0/en/teva-highlights-new-real-world-data-showing-uzedy-risperidone-outperforms-other-long-acting-injectables-in-keeping-schizophrenia-patients-on-treatment-while-reducing-emergency-care.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-18T20:31:00Z",
"summary": "Teva announced real-world data demonstrating that UZEDY (risperidone) extended-release injectable suspension shows superior treatment continuity compared to other long-acting injectables in schizophrenia patients and oral antipsychotics in bipolar I disorder. The data revealed UZ",
"image": "https://ml-eu.globenewswire.com/Resource/Download/c2001734-949b-4cc2-8021-b4b64eda1f13"
},
{
"title": "Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults",
"url": "https://www.globenewswire.com/news-release/2026/09/18/3364951/0/en/teva-announces-new-olanzapine-lai-tev-749-post-hoc-data-highlighting-high-rates-of-stabilization-and-long-term-efficacy-as-once-monthly-subcutaneous-injectable-for-the-treatment-of.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-18T20:30:00Z",
"summary": "Teva presented post hoc data from the Phase 3 SOLARIS trial for TEV-'749, a once-monthly subcutaneous long-acting injectable olanzapine formulation for schizophrenia treatment. Results showed over 56% of participants achieved stabilization, 21% achieved remission after 6+ months,",
"image": "https://ml-eu.globenewswire.com/Resource/Download/c2001734-949b-4cc2-8021-b4b64eda1f13"
},
{
"title": "Lilly Builds Neuroscience into a New Long-Term Growth Driver",
"url": "https://www.zacks.com/stock/news/2986190/lilly-builds-neuroscience-into-a-new-long-term-growth-driver?cid=CS-ZC-FT-analyst_blog|quick_take-2986190",
"source": "Zacks Investment Research",
"date": "2026-09-08T12:27:00Z",
"summary": "Eli Lilly's neuroscience business, currently representing only 2% of revenues, is experiencing strong 32% growth with key products Kisunla and Emgality. The company is aggressively expanding its neuroscience pipeline through acquisitions including AtaiBeckley for treatment-resist",
"image": "https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg"
},
{
"title": "Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/09/07/3357229/0/en/ulcerative-colitis-market-outlook-5-late-stage-drug-candidates-to-watch-delveinsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-07T17:00:00Z",
"summary": "The ulcerative colitis market is experiencing significant growth with emerging therapies addressing unmet needs in moderate-to-severe disease. The market, valued at approximately USD 9.4 billion in 2025, is projected to expand at a CAGR of 7.6% through 2036. Five promising late-s",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
},
{
"title": "Teva\u00a0Announces\u00a0Launch\u00a0of\u00a0Offering\u00a0of\u00a0Senior Notes",
"url": "https://www.globenewswire.com/news-release/2026/09/07/3356981/0/en/teva-announces-launch-of-offering-of-senior-notes.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-07T07:53:00Z",
"summary": "Teva Pharmaceutical announced its intention to issue EUR and USD-denominated senior notes through special purpose finance subsidiaries. The company plans to use net proceeds to redeem certain existing notes, including 6.750% notes due 2028, 7.875% and 7.375% sustainability-linked",
"image": "https://ml-eu.globenewswire.com/Resource/Download/c2001734-949b-4cc2-8021-b4b64eda1f13"
},
{
"title": "Teva Seeks to Boost Neuroscience Portfolio With BioXcel Asset Bid",
"url": "https://www.zacks.com/stock/news/2982619/teva-seeks-to-boost-neuroscience-portfolio-with-bioxcel-asset-bid?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2982619",
"source": "Zacks Investment Research",
"date": "2026-08-31T15:36:00Z",
"summary": "Teva Pharmaceutical has made a bid to acquire certain assets of BioXcel Therapeutics, including Igalmi (dexmedetomidine sublingual film) and the investigational BXCL501 formulation under FDA review for at-home treatment of acute agitation. Teva would pay $57.5 million upfront wit",
"image": "https://staticx-tuner.zacks.com/images/articles/main/c4/390.jpg"
},
{
"title": "Multiple System Atrophy Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/08/26/3351618/0/en/multiple-system-atrophy-clinical-trial-pipeline-gains-momentum-22-companies-lead-the-charge-in-pioneering-new-treatments-delveinsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-26T17:00:00Z",
"summary": "The multiple system atrophy (MSA) clinical trial pipeline is experiencing significant momentum with 22+ companies developing 24+ pipeline drugs. The pipeline is diversifying beyond traditional approaches to include oral small molecules, cell replacement therapies, gene therapies,",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
},
{
"title": "State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption",
"url": "https://www.globenewswire.com/news-release/2026/08/25/3350469/0/en/state-of-the-life-sciences-industry-to-be-reviewed-in-bcc-research-s-2026-second-quarter-outlook-spotlighting-ai-driven-discovery-precision-oncology-and-connected-health-adoption.html",
"source": "GlobeNewswire Inc.",
"date": "2026-08-25T12:54:00Z",
"summary": "BCC Research's mid-year assessment highlights AI-driven discovery, precision oncology, and connected health as major growth themes in the life sciences sector. Key opportunities include smart inhalers with AI integration, genomic profiling platforms, cardiovascular drug innovatio",
"image": "https://ml.globenewswire.com/Resource/Download/d0c282b6-d496-45a8-a941-33fa5c3e824c"
},
{
"title": "Ionis Pharmaceuticals Director Hayden Buys $1.1 Million Shares. What Does This Mean for Investors?",
"url": "https://www.fool.com/coverage/filings/2026/08/03/ionis-pharmaceuticals-director-hayden-buys-usd1-1-million-shares-what-does-this-mean-for-investors/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-08-03T19:17:01Z",
"summary": "Michael R. Hayden, a director at Ionis Pharmaceuticals, purchased 20,000 shares worth $1.1 million on July 30-31, 2026, increasing his total holdings by 34%. The insider purchase signals confidence in the company's RNA-targeted therapy pipeline, which includes recently approved d",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2Fb19f891b451b1982a0d4bbdd1c4c991ed072e0fb-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Novartis vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/07/09/novartis-vs-teva-which-pharmaceutical-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-07-09T16:12:04Z",
"summary": "Novartis and Teva represent different pharmaceutical strategies: Novartis is a stable innovator with high margins and strong cash flow, while Teva is executing a turnaround from generics to biosimilars with improving profitability but higher debt. Despite Novartis's superior fina",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2d10dfb318519977a677bcb00f3da6d28e64e4b0-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/07/06/eli-lilly-and-vs-teva-pharmaceutical-industries-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-07-06T17:09:01Z",
"summary": "Eli Lilly and Teva Pharmaceutical represent two different pharmaceutical strategies: Eli Lilly dominates the high-growth GLP-1 market with blockbuster drugs like Mounjaro and Zepbound, posting 44% revenue growth and trading at a 33x forward P/E. Teva operates in generics and bios",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F5d5d57f05229d5e553cc6e2f816603ec4ca01b17-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
}
]
Data:
[
{
"symbol": "TEVA",
"date": "2026-11-03",
"epsActual": null,
"epsEstimated": 0.72,
"revenueActual": null,
"revenueEstimated": 4196541000,
"lastUpdated": "2026-09-30"
},
{
"symbol": "TEVA",
"date": "2026-07-29",
"epsActual": 0.02,
"epsEstimated": 0.08,
"revenueActual": 4142000000,
"revenueEstimated": 4079986000,
"lastUpdated": "2026-09-30"
},
{
"symbol": "TEVA",
"date": "2026-04-29",
"epsActual": 0.53,
"epsEstimated": 0.5,
"revenueActual": 3982000000,
"revenueEstimated": 3787258000,
"lastUpdated": "2026-07-29"
},
{
"symbol": "TEVA",
"date": "2026-01-28",
"epsActual": 0.96,
"epsEstimated": 0.65,
"revenueActual": 4711000000,
"revenueEstimated": 4316881000,
"lastUpdated": "2026-04-28"
},
{
"symbol": "TEVA",
"date": "2025-11-05",
"epsActual": 0.78,
"epsEstimated": 0.68,
"revenueActual": 4480000000,
"revenueEstimated": 4454812440,
"lastUpdated": "2026-02-05"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "TEVA",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "TEVA",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 3823,
"price": 33.31
},
{
"file_period": "202607a",
"settlement_date": "20260709",
"quantity_fails": 215215,
"price": 33.24
},
{
"file_period": "202607b",
"settlement_date": "20260723",
"quantity_fails": 26824,
"price": 30.15
},
{
"file_period": "202608a",
"settlement_date": "20260812",
"quantity_fails": 907,
"price": 36.48
},
{
"file_period": "202608b",
"settlement_date": "20260826",
"quantity_fails": 7094,
"price": 38.1
},
{
"file_period": "202609a",
"settlement_date": "20260914",
"quantity_fails": 12764,
"price": 37.09
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": [
{
"symbol": "TEVA",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-18",
"reportingCik": "0002112339",
"companyCik": "0000818686",
"transactionType": "M-Exempt",
"securitiesOwned": 15842,
"reportingName": "Savage Brian",
"typeOfOwner": "officer: Interim Chief Legal Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 4503,
"price": 34.7,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526398105/0001193125-26-398105-index.htm"
},
{
"symbol": "TEVA",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-18",
"reportingCik": "0002112339",
"companyCik": "0000818686",
"transactionType": "S-Sale",
"securitiesOwned": 11339,
"reportingName": "Savage Brian",
"typeOfOwner": "officer: Interim Chief Legal Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 4503,
"price": 38.69,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526398105/0001193125-26-398105-index.htm"
},
{
"symbol": "TEVA",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-18",
"reportingCik": "0002112339",
"companyCik": "0000818686",
"transactionType": "S-Sale",
"securitiesOwned": 8814,
"reportingName": "Savage Brian",
"typeOfOwner": "officer: Interim Chief Legal Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2525,
"price": 39.145,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526398105/0001193125-26-398105-index.htm"
},
{
"symbol": "TEVA",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-18",
"reportingCik": "0002112339",
"companyCik": "0000818686",
"transactionType": "S-Sale",
"securitiesOwned": 8500,
"reportingName": "Savage Brian",
"typeOfOwner": "officer: Interim Chief Legal Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 314,
"price": 38.7038,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526398105/0001193125-26-398105-index.htm"
},
{
"symbol": "TEVA",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-18",
"reportingCik": "0002112339",
"companyCik": "0000818686",
"transactionType": "M-Exempt",
"securitiesOwned": 0,
"reportingName": "Savage Brian",
"typeOfOwner": "officer: Interim Chief Legal Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 4503,
"price": 34.7,
"securityName": "Stock Options (right to buy)",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526398105/0001193125-26-398105-index.htm"
},
{
"symbol": "TEVA",
"filingDate": "2026-09-22",
"transactionDate": "2026-09-18",
"reportingCik": "0001258394",
"companyCik": "0000818686",
"transactionType": "S-Sale",
"securitiesOwned": 0,
"reportingName": "MIGNONE ROBERTO",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "I",
"formType": "4",
"securitiesTransacted": 367600,
"price": 39.0555,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526397959/0001193125-26-397959-index.htm"
},
{
"symbol": "TEVA",
"filingDate": "2026-08-25",
"transactionDate": "2026-08-21",
"reportingCik": "0001897057",
"companyCik": "0000818686",
"transactionType": "M-Exempt",
"securitiesOwned": 15571,
"reportingName": "Weiss Amir",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 2500,
"price": 19.61,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526365116/0001193125-26-365116-index.htm"
},
{
"symbol": "TEVA",
"filingDate": "2026-08-25",
"transactionDate": "2026-08-21",
"reportingCik": "0001897057",
"companyCik": "0000818686",
"transactionType": "S-Sale",
"securitiesOwned": 13071,
"reportingName": "Weiss Amir",
"typeOfOwner": "officer: Chief Accounting Officer",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 6945,
"price": 37.6133,
"securityName": "Ordinary Shares",
"url": "https://www.sec.gov/Archives/edgar/data/818686/000119312526365116/0001193125-26-365116-index.htm"
}
],
"congress": [
{
"symbol": "TEVA",
"senateID": "M001111",
"disclosureDate": "2017-06-22",
"transactionDate": "2017-06-15",
"firstName": "Patty",
"lastName": "Murray",
"office": "Patty Murray",
"district": "WA",
"owner": "Spouse",
"assetDescription": "Teva Pharmaceutical Industries Limited",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/07a7470c-ae50-4a37-8c10-cf1c59a69674/"
},
{
"symbol": "TEVA",
"senateID": "K000383",
"disclosureDate": "2016-11-10",
"transactionDate": "2016-10-19",
"firstName": "Angus Stanley",
"lastName": "King",
"office": "Angus S King",
"district": "ME",
"owner": "Spouse",
"assetDescription": "Teva Pharmaceutical Industries Limited",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/7dd32f76-2862-421d-b105-84ff6a5e01cd/"
},
{
"symbol": "TEVA",
"senateID": "G000584",
"disclosureDate": "2020-12-02",
"transactionDate": "2020-11-13",
"firstName": "Greg",
"lastName": "Gianforte",
"office": "Greg Gianforte",
"district": "MT00",
"owner": "Joint",
"assetDescription": "Teva Pharmaceutical Industries Limited American Depositary Shares",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017780.pdf"
},
{
"symbol": "TEVA",
"senateID": "S001206",
"disclosureDate": "2020-05-15",
"transactionDate": "2020-05-07",
"firstName": "Donna",
"lastName": "Shalala",
"office": "Donna Shalala",
"district": "FL27",
"owner": "",
"assetDescription": "Teva Pharmaceutical Industries Limited American Depositary Shares",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20016566.pdf"
},
{
"symbol": "TEVA",
"senateID": "P000523",
"disclosureDate": "2019-07-11",
"transactionDate": "2019-06-19",
"firstName": "David Eugene",
"lastName": "Price",
"office": "David E. Price",
"district": "NC04",
"owner": "",
"assetDescription": "Teva Pharmaceutical Industries Limited American Depositary Shares",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2019/20011985.pdf"
}
],
"dark_pool": [
{
"ticker": "TEVA",
"executed_at": "2026-09-29T21:21:38.302000Z",
"size": 130478.0,
"price": 39.81,
"premium": 5194329.180000001,
"volume": 130478.0,
"trade_code": " "
},
{
"ticker": "TEVA",
"executed_at": "2026-09-29T20:00:28.602000Z",
"size": 58162.0,
"price": 39.81,
"premium": 2315429.22,
"volume": 58162.0,
"trade_code": " "
},
{
"ticker": "TEVA",
"executed_at": "2026-09-29T20:00:03.498000Z",
"size": 5023.0,
"price": 39.81,
"premium": 199965.63,
"volume": 5023.0,
"trade_code": " "
},
{
"ticker": "TEVA",
"executed_at": "2026-09-30T11:18:34.986000Z",
"size": 5000.0,
"price": 40.0,
"premium": 200000.0,
"volume": 5000.0,
"trade_code": " "
},
{
"ticker": "TEVA",
"executed_at": "2026-09-29T20:00:48.834000Z",
"size": 3949.0,
"price": 39.81,
"premium": 157209.69,
"volume": 3949.0,
"trade_code": " "
},
{
"ticker": "TEVA",
"executed_at": "2026-09-29T20:00:20.077000Z",
"size": 3319.0,
"price": 39.81,
"premium": 132129.39,
"volume": 3319.0,
"trade_code": " "
},
{
"ticker": "TEVA",
"executed_at": "2026-09-29T20:00:32.527000Z",
"size": 1408.0,
"price": 39.81,
"premium": 56052.48,
"volume": 1408.0,
"trade_code": " "
},
{
"ticker": "TEVA",
"executed_at": "2026-09-29T20:00:02.459000Z",
"size": 1246.0,
"price": 39.81,
"premium": 49603.26,
"volume": 1246.0,
"trade_code": " "
}
],
"ats": {
"symbol": "TEVA",
"date": "20260929",
"ats_volume": 0,
"total_volume": 3697734,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260929",
"ats_ratio": 0.0
},
{
"date": "20260928",
"ats_ratio": 0.0
},
{
"date": "20260925",
"ats_ratio": 0.0
},
{
"date": "20260924",
"ats_ratio": 0.0
},
{
"date": "20260923",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "TEVA",
"days": [
{
"date": "2026-09-30",
"close": 39.585,
"vwap": 39.93,
"volume": 177680,
"vwap_discount_pct": 0.86
},
{
"date": "2026-09-29",
"close": 39.81,
"vwap": 39.64,
"volume": 6822717,
"vwap_discount_pct": -0.43
},
{
"date": "2026-09-28",
"close": 38.88,
"vwap": 38.8,
"volume": 4306547,
"vwap_discount_pct": -0.2
},
{
"date": "2026-09-25",
"close": 39.19,
"vwap": 39.33,
"volume": 3874734,
"vwap_discount_pct": 0.35
},
{
"date": "2026-09-24",
"close": 40.22,
"vwap": 39.78,
"volume": 7731632,
"vwap_discount_pct": -1.08
}
],
"avg_vwap_discount_pct": -0.1,
"signal": "Neutral"
},
"options_flow": [],
"net_premium": {
"ticker": "TEVA",
"net_call_premium": "134414.00",
"net_put_premium": "-80280.00",
"call_premium": "2067928.00",
"put_premium": "267672.00",
"bullish_premium": "1173811.00",
"bearish_premium": "959117.00",
"put_call_ratio": "0.1872222222222222222222222222",
"iv_rank": "16.2531",
"implied_move_perc": "0.064",
"gex_ratio": "0.39575649777296851727",
"gex_net_change": "89990.8906",
"gex_call": "895689.6202",
"gex_put": "-307994.0503",
"gex_net": 587695.5699,
"gex_call_delta": "11141766.2702",
"gex_put_delta": "-1316826.4982",
"gex_date": "2026-09-30"
},
"hot_chains": [
{
"open_interest": 325,
"volume": 1552,
"last_price": "1.20",
"option_symbol": "TEVA261002C00039000",
"bid_volume": 1025,
"ask_volume": 520,
"avg_price": "0.6303737113402061855670103092",
"nbbo_ask": "1.61",
"nbbo_bid": "0.66"
},
{
"open_interest": 71,
"volume": 1040,
"last_price": "0.68",
"option_symbol": "TEVA261002C00039500",
"bid_volume": 296,
"ask_volume": 719,
"avg_price": "0.6261826923076923076923076925",
"nbbo_ask": "0.87",
"nbbo_bid": "0.68"
},
{
"open_interest": 193,
"volume": 1027,
"last_price": "0.65",
"option_symbol": "TEVA261016C00041000",
"bid_volume": 226,
"ask_volume": 496,
"avg_price": "0.6638461538461538461538461537",
"nbbo_ask": "0.69",
"nbbo_bid": "0.46"
},
{
"open_interest": 150,
"volume": 675,
"last_price": "0.51",
"option_symbol": "TEVA261030C00043000",
"bid_volume": 474,
"ask_volume": 147,
"avg_price": "0.5261333333333333333333333336",
"nbbo_ask": "0.70",
"nbbo_bid": "0.29"
},
{
"open_interest": 896,
"volume": 600,
"last_price": "0.50",
"option_symbol": "TEVA261002C00040000",
"bid_volume": 58,
"ask_volume": 538,
"avg_price": "0.3851833333333333333333333330",
"nbbo_ask": "0.56",
"nbbo_bid": "0.47"
},
{
"open_interest": 17081,
"volume": 597,
"last_price": "1.55",
"option_symbol": "TEVA261218P00037000",
"bid_volume": 472,
"ask_volume": 125,
"avg_price": "1.5981574539363484087102177555",
"nbbo_ask": "1.49",
"nbbo_bid": "1.06"
},
{
"open_interest": 17722,
"volume": 585,
"last_price": "1.00",
"option_symbol": "TEVA261218C00045000",
"bid_volume": 502,
"ask_volume": 83,
"avg_price": "0.8529059829059829059829059829",
"nbbo_ask": "1.52",
"nbbo_bid": "0.74"
},
{
"open_interest": 17473,
"volume": 524,
"last_price": "2.80",
"option_symbol": "TEVA261218C00040000",
"bid_volume": 24,
"ask_volume": 500,
"avg_price": "2.3562977099236641221374045802",
"nbbo_ask": "3.10",
"nbbo_bid": "2.46"
}
],
"gamma_profile": {
"ticker": "TEVA",
"spot": 40.2003,
"date": "2026-09-30",
"flip_point": 38.8,
"net_gex": 587695.57,
"call_walls": [
{
"strike": 40.0,
"gex": 204162.83
},
{
"strike": 39.0,
"gex": 134222.77
},
{
"strike": 45.0,
"gex": 134037.06
}
],
"put_walls": [
{
"strike": 37.0,
"gex": -123741.0
},
{
"strike": 40.0,
"gex": -31728.49
},
{
"strike": 32.0,
"gex": -27190.53
}
],
"by_strike": [
{
"strike": 34.0,
"call_gex": 7006.05,
"put_gex": -19054.68,
"net_gex": -12048.63
},
{
"strike": 34.5,
"call_gex": 8.83,
"put_gex": -21.76,
"net_gex": -12.93
},
{
"strike": 35.0,
"call_gex": 32074.41,
"put_gex": -11811.31,
"net_gex": 20263.11
},
{
"strike": 35.5,
"call_gex": 6.87,
"put_gex": -135.74,
"net_gex": -128.87
},
{
"strike": 36.0,
"call_gex": 4800.84,
"put_gex": -8121.85,
"net_gex": -3321.02
},
{
"strike": 36.5,
"call_gex": 236.46,
"put_gex": -238.45,
"net_gex": -1.99
},
{
"strike": 37.0,
"call_gex": 43228.78,
"put_gex": -123741.0,
"net_gex": -80512.22
},
{
"strike": 37.5,
"call_gex": 171.05,
"put_gex": -7817.7,
"net_gex": -7646.65
},
{
"strike": 38.0,
"call_gex": 20418.67,
"put_gex": -8642.43,
"net_gex": 11776.24
},
{
"strike": 38.5,
"call_gex": 5187.78,
"put_gex": -1370.09,
"net_gex": 3817.69
},
{
"strike": 39.0,
"call_gex": 134222.77,
"put_gex": -16989.2,
"net_gex": 117233.57
},
{
"strike": 39.5,
"call_gex": 26812.95,
"put_gex": -6339.76,
"net_gex": 20473.19
},
{
"strike": 40.0,
"call_gex": 204162.83,
"put_gex": -31728.49,
"net_gex": 172434.33
},
{
"strike": 40.5,
"call_gex": 910.87,
"put_gex": -1908.62,
"net_gex": -997.75
},
{
"strike": 41.0,
"call_gex": 27844.92,
"put_gex": -3607.84,
"net_gex": 24237.07
},
{
"strike": 41.5,
"call_gex": 551.2,
"put_gex": -15.99,
"net_gex": 535.21
},
{
"strike": 42.0,
"call_gex": 118114.03,
"put_gex": -848.03,
"net_gex": 117265.99
},
{
"strike": 42.5,
"call_gex": 868.07,
"put_gex": 0.0,
"net_gex": 868.07
},
{
"strike": 43.0,
"call_gex": 41562.49,
"put_gex": -869.48,
"net_gex": 40693.01
},
{
"strike": 43.5,
"call_gex": 9.5,
"put_gex": 0.0,
"net_gex": 9.5
},
{
"strike": 44.0,
"call_gex": 11704.82,
"put_gex": -362.57,
"net_gex": 11342.25
},
{
"strike": 45.0,
"call_gex": 134037.06,
"put_gex": -877.83,
"net_gex": 133159.23
},
{
"strike": 46.0,
"call_gex": 4833.49,
"put_gex": 0.0,
"net_gex": 4833.49
},
{
"strike": 47.0,
"call_gex": 3998.3,
"put_gex": -642.33,
"net_gex": 3355.98
},
{
"strike": 48.0,
"call_gex": 297.34,
"put_gex": 0.0,
"net_gex": 297.34
}
]
},
"oi_changes": {
"net_call_oi_change": -14,
"net_put_oi_change": 0,
"top": [
{
"strike": null,
"oi_change": -11,
"type": "call"
},
{
"strike": null,
"oi_change": -2,
"type": "call"
},
{
"strike": null,
"oi_change": -1,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "put"
}
]
},
"opds": {
"opds": -8.5,
"D": -25.8,
"P": 35.8,
"O": -15.7,
"C": 33.1,
"signal": "NEUTRAL",
"direction": "bearish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": 15.5,
"T": 56.8,
"RS": 23.0,
"V": 58.2,
"F": 10.1,
"OI": -100.0,
"S": null,
"IV": 8.2,
"B": null,
"Liquidity": 32.9,
"OpeningConfidence": null,
"FlowAgreement": 33.3,
"StrikeBreadth": null
},
"drivers": [
"- open-interest change -100",
"+ price/volume +58",
"+ trend +57",
"+ relative strength +23"
]
}
}
Data:
{
"vix": 15.67,
"sp500": 7743.41,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.36,
"hy_spread": 2.8,
"treasury": {
"date": "2026-09-28",
"month1": 4.04,
"month2": 4.2,
"month3": 4.28,
"month6": 4.41,
"year1": 4.59,
"year2": 4.92,
"year3": 5.01,
"year5": 5.06,
"year7": 5.15,
"year10": 5.24,
"year20": 5.6,
"year30": 5.56
},
"events": [
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.2%",
"actual": null,
"minutes_until": -8
},
{
"title": "Final GDP q/q",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "1.5%",
"previous": "1.5%",
"actual": null,
"minutes_until": -8
},
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.3%",
"actual": null,
"minutes_until": 2871
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "90K",
"previous": "162K",
"actual": null,
"minutes_until": 2871
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 2871
}
]
}
Data:
{
"days": 103,
"patterns": [
{
"name": "VWAP Touch",
"count": 103,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 103,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 101,
"pct": 98
},
{
"name": "Woodie Pivot Touch",
"count": 99,
"pct": 96
},
{
"name": "PDH/PDL Touch",
"count": 90,
"pct": 87
},
{
"name": "Open Retracement",
"count": 77,
"pct": 75
},
{
"name": "Gap Fill",
"count": 72,
"pct": 70
},
{
"name": "Darvas Box",
"count": 23,
"pct": 22
},
{
"name": "High Vol Open",
"count": 19,
"pct": 18
},
{
"name": "Power Hour",
"count": 14,
"pct": 14
}
]
}